Peter Connick
Edinburgh, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Optical coherence tomography in secondary progressive multiple sclerosis: cross-sectional and longitudinal exploratory analysis from the MS-SMART randomised controlled trial.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: August 08, 2024
Fatigue in early multiple sclerosis: MRI metrics of neuroinflammation, relapse and neurodegeneration.
Journal: Brain communications
Published: February 22, 2024
Brain reserve and physical disability in secondary progressive multiple sclerosis.
Journal: BMJ neurology open
Published: February 05, 2024
Systematic, comprehensive, evidence-based approach to identify neuroprotective interventions for motor neuron disease: using systematic reviews to inform expert consensus.
Journal: BMJ open
Published: February 01, 2023
Patterns of brain atrophy in recently-diagnosed relapsing-remitting multiple sclerosis.
Journal: PloS one
Published: November 07, 2022
Network analysis characterizes key associations between subjective fatigue and specific depressive symptoms in early relapsing-remitting multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: September 02, 2022
Remyelination varies between and within lesions in multiple sclerosis following bexarotene.
Journal: Annals of clinical and translational neurology
Published: June 16, 2022
The Patient Health Questionnaire (PHQ-9) as a tool to screen for depression in people with multiple sclerosis: a cross-sectional validation study.
Journal: BMC psychology
Published: April 13, 2022
Longitudinal retinal imaging study of newly diagnosed relapsing-remitting multiple sclerosis in Scottish population: baseline and 12 months follow-up profile of FutureMS retinal imaging cohort.
Journal: BMJ open ophthalmology
Published: March 29, 2022
Efficacy of Fluoxetine, Riluzole and Amiloride in treating neuropathic pain associated with secondary progressive multiple sclerosis. Pre-specified analysis of the MS-SMART double-blind randomised placebo-controlled trial.
Journal: Multiple sclerosis and related disorders
Published: March 25, 2022
Rationale and design of the brain magnetic resonance imaging protocol for FutureMS: a longitudinal multi-centre study of newly diagnosed patients with relapsing-remitting multiple sclerosis in Scotland.
Journal: Wellcome open research
Published: March 02, 2022
Last Updated: 09/26/2026